NCT06947603

Brief Summary

In oral surgery, the operation of the impacted third molar is one of the most common surgical procedures performed by oral and maxillofacial surgeons .Several attempts have been made to reduce the postoperative outcome of the removal of the third molar post-surgery.The bioactive components in Inula extracts consist of sesquiterpene lactones, and the major components are alantolactone and isoalantolactone .\]. Inula has Antioxidant, antihyperglycemic, antimicrobial, antibacterial, antifungal, anticancer and anti-inflammatory effects. the purpose of this study was to assess the effects of inula viscosa on the postoperative period of the third molar surgery by evaluating bleeding, and healing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 27, 2025

Completed
Last Updated

April 27, 2025

Status Verified

April 1, 2025

Enrollment Period

1.3 years

First QC Date

April 3, 2025

Last Update Submit

April 25, 2025

Conditions

Keywords

Inula ViscosaPainEdemaTrismusLower Third Molars

Outcome Measures

Primary Outcomes (2)

  • questionnaire

    Measurement of bleeding: A subjective method was used to compare post-operative bleeding between the two techniques in this clinical trial. The patient was asked to count the number of gauze pads for the patient to bite on gauzes used to stop bleeding, for each surgical site, on each day post-operatively, also, the patient reported the time needed to achieve a bleeding-free surgical site

    postprocedural, up to 12 hours

  • healing after surgery as assessed by Alkadi 2018

    The assessment of socket healing was carried out at one week after surgery using a five-grade index to measure the degree of socket epithelization, which was designed by (Alkadi 2018) as follows : * Very poor (1) : Clinical criteria Tissue color: ˃ 50% of gingivae red , Response to palpation: bleeding, Granulation tissue: present, Incision margin: not epithelialized, with loss of epithelium , beyond margins .Suppuration: present * Poor (2) : Tissue color:˃ 50% of gingivae red, Response to palpation: bleeding, Granulation tissue: present Incision margin: not epithelialized, with connective tissue exposed, Suppuration: none * Good (3) : Tissue color: ˂ 50% of gingivae red, Response to palpation: no bleeding, Granulation tissue: none, Incision margin: no connective tissue exposed, Suppuration: none * Very good (4) :Tissue color: ˂ 25% of gingivae red, Response to palpation: no bleeding, Granulation

    time 1: one week after surgery

Study Arms (2)

inula viscosa extract was used for one side of patients after surgical lower third molar removal

ACTIVE COMPARATOR

The study sample was divided into two equal groups based on the type of pharmaceutical substance applied within the alveolar socket after the extraction of impacted molars. In the first group (Inula group), an extract of INULA was used

Procedure: inula viscosa extractProcedure: no inula viscosa extract

nothing was used for other side of patients after surgical lower third molar removal

ACTIVE COMPARATOR

The study sample was divided into two equal groups based on the type of pharmaceutical substance applied within the alveolar socket after the extraction of impacted molars. In the second group (control group), nothing was used

Procedure: inula viscosa extractProcedure: no inula viscosa extract

Interventions

the topical gel of inula viscosa was applied to one side after the extraction of the impacted molar in each patient, while the other side was left without the application of any pharmaceutical substance after extraction

inula viscosa extract was used for one side of patients after surgical lower third molar removalnothing was used for other side of patients after surgical lower third molar removal

the other side of patient was left without the application of inula viscosa extract after lower third molar extraction.

inula viscosa extract was used for one side of patients after surgical lower third molar removalnothing was used for other side of patients after surgical lower third molar removal

Eligibility Criteria

Age18 Years - 35 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsfemale participate has to be not pregnant or lactating
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients have bilateral lower impacted third molars (those that can only be surgically extracted through bone osteotomy with or without the need for tooth sectioning)
  • good general health with no systemic diseases, ,

You may not qualify if:

  • non-smokers,
  • no medication taken that could influence wound healing after surgery,
  • and no oral inflammation, such as periodontal disease,
  • for woman not pregnant or lactating.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al Wataniya Private University

Hama, Hama Government, 00000, Syria

Location

MeSH Terms

Conditions

HemorrhagePainEdemaTrismus

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsSpasmNeuromuscular ManifestationsNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior lecturer

Study Record Dates

First Submitted

April 3, 2025

First Posted

April 27, 2025

Study Start

November 20, 2023

Primary Completion

March 1, 2025

Study Completion

March 29, 2025

Last Updated

April 27, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations